anti-sera for diagnotics in blood banks
דיאמד(ישראל) בע"מ - מומחה - סרומים לאבחון קבוצות דם לשימוש בבנק דם
לבופר פלוס 125
teva pharmaceutical indust.ltd - benserazide as hydrochloride 25 mg; levodopa 100 mg - capsules - levodopa - for the relief of symptoms associated with parkinson's disease.
לבופר פלוס 250
teva pharmaceutical indust.ltd - benserazide as hydrochloride 50 mg; levodopa 200 mg - capsules - levodopa and decarboxylase inhibitor - for the relief of symptoms associated with parkinson's disease.
לבופר פלוס 250
teva pharmaceutical indust.ltd - benserazide as hydrochloride 50 mg; levodopa 200 mg - capsules - levodopa and decarboxylase inhibitor - for the relief of symptoms associated with parkinson's disease.
textile implants for urogynaecology
dolphin medical ltd. - רופא - משתלי בד למערכת האורוגניקולוגית
הפסרה
glaxo smith kline (israel) ltd - adefovir dipivoxil - טבליה - adefovir dipivoxil 10 mg - adefovir dipivoxil - adefovir dipivoxil - hepsera is indicated for the treatment of chronic hepatitis b in adults with evidence of hepatitis b viral replication. reductions in viral replication and improvements in liver function have also been demonstrated in supportive studies in a limited number of chronic hepatitis b patients with genotypic evidence of lamivudine-resistance, including patients with compensated or decompensated liver disease and patients co-infected with hiv.
סרמאן
אקולאב זהר דליה - תרחיץ ניקוי עדין במיוחד למקלחת ולחפיפת שיער
סרמאן סנסיטיב
אקולאב זהר דליה - תרחיץ ניקוי עדין במיוחד למקלחת, לטיפול עדין ולחפיפת שיער
קומטן ®
novartis pharma services ag - entacapone 200 mg - film coated tablets - entacapone - entacapone is indicated as an adjunct to standard preparations of levodopa/benserazide or levodopa/carbidopa for use in patients with parkinson`s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.
קומטן
novartis israel ltd - entacapone - טבליות מצופות פילם - entacapone 200 mg - entacapone - entacapone - entacapone is indicated as an adjunct to standard preparations of levodopa/benserazide or levodopa/carbidopa for use in patients with parkinson`s disease and end-of-dose motor fluctuations who cannot be stabilised on those combinations.